Amicus (FOLD) Filings for AT-GAA in Pompe Disease Accepted b

The European Medicines Agency accepts Amicus Therapeutics' (FOLD) MAA for AT-GAA, a potential treatment for Pompe disease.

Related Keywords

Endo International , Sanofi Myozyme Lumizyme , Amicus Therapeutics , European Medicines Agency , Zacks Investment Research , Committee For Medicinal Products Human Use , Earnings Of Endo International , Medicinal Products , Human Use , Zacks Investment , Breakthrough Therapy , Infantile Onset , Late Onset Pompe , Zacks Rank , Strong Buy , Precision Biosciences , Legal Marijuana Looking , Investment Research , Zack Marijuana Moneymakers , Watch List , Download Marijuana Moneymakers , Stocks , Finance ,